Biotech News
Organogenesis Applauds CMS’s Significant Step In Payment Reform
investors.organogenesis.com2026-05-06 15:01 EST
With evidence-based portfolio including technologies in each FDA category, we believe we are best positioned in the skin substitutes market for 2026 and beyond CANTON, Mass., Nov. 03, 2025 (GLOBE NEWSWIRE) -- Organogenesis Holdings Inc. (Nasdaq: ORGO), a leading regenerative medicine company